Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease

Hum Mol Genet. 2003 Jun 1;12(11):1223-31. doi: 10.1093/hmg/ddg134.

Abstract

Synphilin-1 is linked to the pathogenesis of Parkinson's disease (PD) based on its identification as an alpha-synuclein (PARK1) and parkin (PARK2) interacting protein. Moreover, synphilin-1 is a component of Lewy bodies (LB) in brains of sporadic PD patients. Therefore, we performed a detailed mutation analysis of the synphilin-1 gene in 328 German familial and sporadic PD patients. In two apparently sporadic PD patients we deciphered a novel C to T transition in position 1861 of the coding sequence leading to an amino acid substitution from arginine to cysteine in position 621 (R621C). This mutation was absent in a total of 702 chromosomes of healthy German controls. To define a possible role of mutant synphilin-1 in the pathogenesis of PD we performed functional analyses in SH-SY5Y cells. We found synphilin-1 capable of producing cytoplasmic inclusions in transfected cells. Moreover we observed a significantly reduced number of inclusions in cells expressing C621 synphilin-1 compared with cells expressing wild-type (wt) synphilin-1, when subjected to proteasomal inhibition. C621 synphilin-1 transfected cells were more susceptible to staurosporine-induced cell death than cells expressing wt synphilin-1. Our findings argue in favour of a causative role of the R621C mutation in the synphilin-1 gene in PD and suggest that the formation of intracellular inclusions may be beneficial to cells and that a mutation in synphilin-1 that reduces this ability may sensitize neurons to cellular stress.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcysteine / analogs & derivatives*
  • Acetylcysteine / pharmacology
  • Adult
  • Aged
  • Amino Acid Sequence
  • Carrier Proteins / drug effects
  • Carrier Proteins / genetics*
  • Carrier Proteins / metabolism
  • Case-Control Studies
  • Cell Death / drug effects
  • Cell Death / genetics
  • Cells, Cultured
  • Cysteine Endopeptidases
  • Cysteine Proteinase Inhibitors / pharmacology
  • Female
  • Green Fluorescent Proteins
  • Humans
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Multienzyme Complexes / antagonists & inhibitors
  • Mutation*
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / genetics*
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects
  • Neurons / pathology
  • Neurons / physiology
  • Parkinson Disease / genetics*
  • Proteasome Endopeptidase Complex
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Staurosporine / pharmacology
  • Synucleins
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism
  • alpha-Synuclein

Substances

  • Carrier Proteins
  • Cysteine Proteinase Inhibitors
  • Luminescent Proteins
  • Multienzyme Complexes
  • Nerve Tissue Proteins
  • Recombinant Fusion Proteins
  • SNCA protein, human
  • SNCAIP protein, human
  • Synucleins
  • alpha-Synuclein
  • lactacystin
  • Green Fluorescent Proteins
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • Staurosporine
  • Acetylcysteine